SGD Pharma and Corning Incorporated entities have set up a joint venture in India for a new glass tubing facility to expand pharmaceutical manufacturing in Telangana, India. Combining SGD Pharma’s vial-converting expertise with Corning’s proprietary glass-coating technology, the collaboration will enhance vial quality, improve filling-line productivity, and speed the global delivery of injectable treatments. The joint venture will help drugmakers respond to increasingly complex capacity and quality issues while meeting global demand for critical medicines.
Reference could be made to the following link for the transaction: SGD Pharma x Corning News Release_080623.pdf (sgd-pharma.com). JSA advised SGD Pharma.
Our Transaction Team Comprised Partner – Rinku Ambekar, Principal Associate – Reshma Oak.
Our Competition Team Partner – Vaibhav Choukse and Ela Bali, Senior Associate – Aditi Khanna.